Treatment with conjugates showed a trend toward increased production of IgG2a antibodies (Figure 5B ).
← all excerpts
Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.
1
—
—